148 related articles for article (PubMed ID: 1009883)
1. Current trends in chemotherapy of leukaemias lymphomas and multiple myeloma.
Kasili EG
East Afr Med J; 1976 Sep; 53(9):554-9. PubMed ID: 1009883
[No Abstract] [Full Text] [Related]
2. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
3. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
4. The current status of cancer chemotherapy for selected human neoplasms.
Rubin RN
Clin Ther; 1981; 4(2):74-94. PubMed ID: 7028265
[No Abstract] [Full Text] [Related]
5. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
6. Developments in the treatment of leukaemias and lymphomas.
Ann Hematol; 1995 Jun; 68(3 Suppl):1-8. PubMed ID: 7619921
[No Abstract] [Full Text] [Related]
7. [Application of bis-diketopiperazine in the treatment of acute leukemia and other malignant blood disorders].
Yang QE; Zhang A
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):17-20. PubMed ID: 6238688
[No Abstract] [Full Text] [Related]
8. The rationale of autologous bone marrow transplantation.
Mandelli F; Meloni G
Bone Marrow Transplant; 1991; 7 Suppl 2():66-7. PubMed ID: 1878725
[No Abstract] [Full Text] [Related]
9. Cancer chemotherapy.
Smith LH
Major Probl Intern Med; 1971; 1():1-197. PubMed ID: 5005758
[No Abstract] [Full Text] [Related]
10. Second malignancies and chemotherapeutic agents.
Kyle RA
Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
[No Abstract] [Full Text] [Related]
11. [Principles of treatment of hemoblastoses under ambulatory conditions].
Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
[No Abstract] [Full Text] [Related]
12. Clinical trials referral resource. Clinical trials with arsenic trioxide.
Murgo AJ; McBee WL; Cheson BD
Oncology (Williston Park); 2000 Feb; 14(2):206, 211, 215-6 passim. PubMed ID: 10736809
[No Abstract] [Full Text] [Related]
13. New agents for the treatment of multiple myeloma and non-Hodgkin lymphoma.
Oken MM
Cancer; 1992 Aug; 70(4 Suppl):946-8. PubMed ID: 1638466
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance to DNA topoisomerase I and II inhibitors in human leukemia, lymphoma, and multiple myeloma.
Valkov NI; Sullivan DM
Semin Hematol; 1997 Oct; 34(4 Suppl 5):48-62. PubMed ID: 9408961
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
16. [Cytostatic therapy of hemoblastosis].
Ehrhart H
Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
[No Abstract] [Full Text] [Related]
17. The internist's role in the management of cancer.
Li MC; Kanwal G
Mod Treat; 1971 Nov; 8(4):914-43. PubMed ID: 4334186
[No Abstract] [Full Text] [Related]
18. [Current status of chemotherapy of malignant diseases of the hematopoietic organs].
Ducach G
Rev Med Chil; 1970 May; 98(5):309-21. PubMed ID: 5478171
[No Abstract] [Full Text] [Related]
19. Malignant diseases of the blood.
Haurani FI; Thorling KH
Pa Med; 1966 Nov; 69(11):33-6. PubMed ID: 5342122
[No Abstract] [Full Text] [Related]
20. 2nd International Congress on Leukemia, Lymphoma and Myeloma.
Arat M; Ozsan GH; Yenerel MN; Cetin M; Ozcan M
Expert Rev Hematol; 2009 Oct; 2(5):509-12. PubMed ID: 21083016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
